Novartis AG
NYSE:NVS

Watchlist Manager
Novartis AG Logo
Novartis AG
NYSE:NVS
Watchlist
Price: 138.3 USD -0.3%
Market Cap: 280B USD

Wall Street
Price Targets

NVS Price Targets Summary
Novartis AG

Wall Street analysts forecast NVS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NVS is 138.97 USD with a low forecast of 112.15 USD and a high forecast of 168 USD.

Lowest
Price Target
112.15 USD
19% Downside
Average
Price Target
138.97 USD
0% Upside
Highest
Price Target
168 USD
21% Upside
Novartis AG Competitors:
Price Targets
STAR
Strides Pharma Science Ltd
42% Upside
IMP
Imexpharm Corp
2% Upside
4552
JCR Pharmaceuticals Co Ltd
6% Downside
SDZ
Sandoz Group AG
8% Downside
600195
China Animal Husbandry Industry Co Ltd
4% Upside
JBCHEPHARM
J B Chemicals and Pharmaceuticals Ltd
13% Upside
CLN
Celon Pharma SA
25% Upside

Revenue
Forecast

Revenue Estimate
Novartis AG

For the last 13 years the compound annual growth rate for Novartis AG's revenue is -1%. The projected CAGR for the next 4 years is 5%.

-1%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Novartis AG

For the last 13 years the compound annual growth rate for Novartis AG's operating income is 3%. The projected CAGR for the next 4 years is 12%.

3%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-24%
Average Miss

Net Income
Forecast

Net Income Estimate
Novartis AG

For the last 13 years the compound annual growth rate for Novartis AG's net income is 2%. The projected CAGR for the next 4 years is 16%.

2%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-8%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NVS's stock price target?
Price Target
138.97 USD

According to Wall Street analysts, the average 1-year price target for NVS is 138.97 USD with a low forecast of 112.15 USD and a high forecast of 168 USD.

What is Novartis AG's Revenue forecast?
Projected CAGR
5%

For the last 13 years the compound annual growth rate for Novartis AG's revenue is -1%. The projected CAGR for the next 4 years is 5%.

What is Novartis AG's Operating Income forecast?
Projected CAGR
12%

For the last 13 years the compound annual growth rate for Novartis AG's operating income is 3%. The projected CAGR for the next 4 years is 12%.

What is Novartis AG's Net Income forecast?
Projected CAGR
16%

For the last 13 years the compound annual growth rate for Novartis AG's net income is 2%. The projected CAGR for the next 4 years is 16%.

Back to Top